Effect of lysed Enterococcus faecalis FK-23 on allergen-induced immune responses and intestinal microflora in antibiotic-treated weaning mice

Journal of Investigational Allergology and Clinical Immunology

Volumn 17, Issue 2, 2007, Pages 70-76

  Shimada, T ^a,b,c   Cheng, Lei ^b,c   Shi, H B ^b,c,d   Hayashi, A ^a   Motonaga, C ^a   Tang, J ^e   Enomoto, K ^f   Enomoto, T ^g  

^a Nichinichi Pharmaceutical Co Ltd   (Japan)

^b NANJING MEDICAL UNIVERSITY   (China)

^c International Centre for Allergy Research   (Japan)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

^e CULTECH LTD   (United Kingdom)

^f OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^g JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

Author keywords

Antibiotics; Enterococcus faecalis; Eosinophils; Immunoglobulins; Intestinal microflora; Lactobacillus

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2A; POLLEN ANTIGEN; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENTEROCOCCUS FAECALIS; EOSINOPHIL; FEMALE; IMMUNE RESPONSE; INTESTINE FLORA; LACTOBACILLUS; MOUSE; NONHUMAN; WEANING;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; CRYPTOMERIA; DISEASE MODELS, ANIMAL; ENTEROCOCCUS FAECALIS; EOSINOPHILS; FECES; FEMALE; HYPERSENSITIVITY, IMMEDIATE; IMMUNIZATION; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; PROBIOTICS; RHINITIS, ALLERGIC, SEASONAL; WEANING;

EID: 34247246671     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet. 1998;351:1225-32.
2. von Mutius E. The burden of childhood asthma. Arch Dis Child. 2000;82 Suppl 2:II2-5.
3. von Mutius E. The environmental predictors of allergic disease. J Allergy Clin Immunol. 2000;105:9-19.
4. Farooqi IS, Hopkin JM. Early childhood infection and atopic disorder. Thorax. 1998;53:927-32.
5. Wickens K, Pearce N, Crane J, Beasley R. Antibiotic use in early childhood and the development of asthma. Clin Exp Allergy. 1999;29:766-71.
6. Droste JH, Wieringa MH, Weyler JJ, Nelen VJ, Vermeire PA, Van Bever HP. Does the use of antibiotics in early childhood increase the risk of asthma and allergic disease? Clin Exp Allergy. 2000;30:1547-53.
7. McKeever TM, Lewis SA, Smith C, Collins J, Heatlie H, Frischer M, Hubbard R. Early exposure to infections and antibiotics and the incidence of allergic disease: a birth cohort study with the West Midlands General Practice Research Database. J Allergy Clin Immunol. 2002;109:43-50.
8. Celedon JC, Fuhlbrigge A, Rifas-Shiman S, Weiss ST, Finkelstein JA. Antibiotic use in the first year of life and asthma in early childhood. Clin Exp Allergy. 2004;34:1011-6.
9. Johnson CC, Ownby DR, Alford SH, Havstad SL, Williams LK, Zoratti EM, Peterson EL, Joseph CL. Antibiotic exposure in early infancy and risk for childhood atopy. J Allergy Clin Immunol. 2005;115:1218-24.
10. Oyama N, Sudo N, Sogawa H, Kubo C. Antibiotic use during infancy promotes a shift in the T(H)1/T(H)2 balance toward T(H)2-dominant immunity in mice. J Allergy Clin Immunol. 2001;107:153-9.
11. Sudo N, Yu XN, Aiba Y, Oyama N, Sonoda J, Koga Y, Kubo C. An oral introduction of intestinal bacteria prevents the development of a long-term Th2-skewed immunological memory induced by neonatal antibiotic treatment in mice. Clin Exp Allergy. 2002;32:1112-6.
12. Shimada T, Cheng L, Ide M, Fukuda S, Enomoto T, Shirakawa T. Effect of lysed Enterococcus faecalis FK-23 (LFK) on allergen-induced peritoneal accumulation of eosinophils in mice. Clin Exp Allergy. 2003;3:684-7.
13. Shimada T, Cheng L, Yamazaki A, Ide M, Motonaga C, Yasueda H, Enomoto K, Enomoto T, Shirakawa T. Effects of lysed Enterococcus faecalis FK-23 on allergen-induced serum antibody responses and active cutaneous anaphylaxis in mice. Clin Exp Allergy. 2004;34:1784-8.
14. Shimada T, Cheng L, Enomoto T, Yang X, Miyoshi A, Shirakawa T. Lysed Enterococus faecalis FK-23 oral administration reveals inverse association between tuberculin responses and clinical manifestations in perennial allergic rhinitis: a preliminary study. J Investig Allergol Clin Immunol. 2004;14:187-92.
15. Yasueda H, Yui Y, Shimizu T, Shida T. Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria Japonica) pollen. J Allergy Clin Immunol. 1983;71:77-86.
16. Kaneko M, Yazumichi H, Takatsu K, Matsumoto S. Role of interleukin-5 in local accumulation of eosinophils in mouse allergic peritonitis. Int Arch Allergy Appl Immunol. 1991;96:41-5.
17. Mitsuoka T, Sega T, Yamamoto S. Eine verbesserte Methodik der Darmflora von Menschen und Tieren. Zentralbl Bacteriol. (Orig. A) 1965;195:455-69.
18. Benno Y, Mitsuoka T. Impact of Bifidobacterium longum on human fecal microflora. Microbiol Immunol. 1992;36:683-94.
19. Hopkin JM. Early life receipt of antibiotics and atopic disorder. Clin Exp Allergy. 1999;29:733-4.
20. Marra F, Lynd L, Coombes M, Richardson K, Legal M, Fitzgerald JM, Marra CA. Does antibiotic exposure during infancy lead to development of asthma?: a systematic review and metaanalysis. Chest. 2006;129:610-8.
21. Madden JA, Plummer SF, Tang J, Garaiova I, Plummer NT, Herbison M, Hunter JO, Shimada T, Cheng L, Shirakawa T. Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: a double-blind, placebo-controlled pilot study. Int Immunopharmacol. 2005;5:1091-7.
22. Groner JI, Edmiston CE Jr, Krepel CJ, Telford GL, Condon RE. The efficacy of oral antimicrobials in reducing aerobic anaerobic colonic mucosal flora. Arch Surg. 1989;124:281-4.
23. Bjorksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2- year-old children. Clin Exp Allergy. 1999;29:342-6.
24. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001;357:1076-9.
25. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomized placebo-controlled trial. Lancet. 2003;361:1869-71.
26. Klijn N, Weerkamp AH, De Vos WM. Genetic marking of Lactobacillus lactis shows its survival in the human gastrointestinal tract. Appl Environ Microbiol. 1995;61:2771-4.
27. Vaarala O. Immunological effects of probiotics with special reference to lactobacilli. Clin Exp Allergy. 2003;33:1634-40.